Xenetic Biosciences, Inc. 8-K

What Happened
Xenetic Biosciences, Inc. (XBIO) announced its results of operations and financial condition for the year ended December 31, 2025. The company issued a press release dated March 13, 2026 reporting those results; the press release is furnished as Exhibit 99.1 to the Form 8-K and was filed under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Date of filing and press release: March 13, 2026.
• Reporting period: Year ended December 31, 2025.
• Form 8-K Items reported: Item 2.02 (results of operations and financial condition) and Item 9.01 (exhibits).
• Exhibits included: Exhibit 99.1 (press release) and Exhibit 104 (Inline XBRL interactive data).

Why It Matters
This 8-K signals that Xenetic has publicly reported its full-year 2025 financial results; the press release will contain the specific earnings, revenue, expense, and liquidity figures investors need to evaluate the company’s recent performance. Retail investors should review the attached press release and the company’s filings (including the Inline XBRL data) for the detailed financial metrics and any management commentary on results, guidance, or cash runway that could affect share valuation or near-term expectations.